3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
23
Breast Neoplasms
22
Carcinoma, Non-Small-Cell Lung
17
Rectal Neoplasms
13
Prostatic Neoplasms
13
Gliosarcoma
12
Lung Neoplasms
10
Head and Neck Neoplasms
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Neoplasms
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Adenocarcinoma Of Esophagus
8
Sarcoma
7
Neoplasm Metastasis
7
Central Nervous System Neoplasms
7
Pancreatic Neoplasms
6
Melanoma
6
Glioma
6
Carcinoma, Squamous Cell
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Burkitt Lymphoma
5
Oropharyngeal Neoplasms
4
Medulloblastoma
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Interventions
Gemcitabine
5
Paclitaxel
4
Nivolumab
3
cobimetinib
2
atezolizumab
2
adavosertib
2
Ramucirumab
2
N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide
2
Carboplatin
2
zansecimab
1
tocilizumab
1
tivozanib
1
tislelizumab
1
temsirolimus
1
ridaforolimus
1
plocabulin
1
pexidartinib
1
pevonedistat
1
pembrolizumab
1
pamiparib
1
obinutuzumab
1
necitumumab
1
liposomal doxorubicin
1
lenvatinib
1
glasdegib
1
futuximab
1
demplatin pegraglumer
1
birinapant
1
avelumab
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumors
×
Radiation
×
Clear all
No trials found.